Drug intelligence / Profile preview

esterified hyaluronic acid matrix

Development stage
Preclinical
Lead developer
Anika Therapeutics
Administration
Topical
01

Overview

Esterified hyaluronic acid matrix (eHAM) is a bioresorbable wound scaffold composed of HYAFF, a benzyl ester of hyaluronic acid. It is designed to provide a three-dimensional extracellular matrix (ECM) that facilitates the migration of fibroblasts and endothelial cells, promoting angiogenesis and the formation of organized granulation tissue, often referred to as a neodermis. The matrix is typically bilayered, featuring a non-woven fiber layer of esterified hyaluronic acid and a semi-permeable silicone top layer that acts as a temporary epidermis to control moisture loss and protect the wound from external contamination. It is primarily indicated for the management of chronic wounds, such as diabetic foot ulcers and venous leg ulcers, as well as acute wounds like deep burns and surgical excisions, often serving as a preparatory bed for split-thickness skin grafting (STSG).

Brand names
HyalomatrixHyalomatrix PA
Other names
eHAMhyaluronic acid benzyl ester matrixbenzyl ester of hyaluronic acidhyaluronic acid benzyl ester
02

Targets

CD44 (CD44 antigen)HMMR

Beyond the preview

Go deeper on esterified hyaluronic acid matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on esterified hyaluronic acid matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call